Pediatrix Medical Group stock trades 8.2 percent below its 52-week high?

Published on 09/25/2026 at 15:25 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Pediatrix Medical Group stock delivered adjusted EPS of USD 0.63 in Q2 2026, 10.5 percent above consensus. Revenue rose 4.1 percent to USD 487.8 million, while patient volumes fell 2.1 percent.

MD, US6036761002, Illustration mit AI erstellt.

Pediatrix Medical Group (ISIN US6036761002) stood at USD 25.66 on the NYSE on September 24, 2026, 8.2 percent below its 52-week high of USD 27.94. The stock's latest quarterly picture combines 4.1 percent revenue growth with a 2.1 percent decline in same-unit patient service volumes.

Revenue grows while volumes fall

According to Yahoo Finance, Pediatrix reported second-quarter 2026 adjusted EPS of USD 0.63, beating the Zacks consensus estimate by 10.5 percent. Net revenue reached USD 487.8 million, up 4.1 percent year over year and 2.2 percent above the revenue estimate.

The revenue mix explains the tension in the figures. Yahoo Finance reported that same-unit reimbursement-related revenue rose 4 percent, offsetting the 2.1 percent fall in patient-volume revenue. Adjusted EBITDA increased to USD 76.4 million from USD 73.2 million, a 4.4 percent year-over-year gain.

Guidance sets the operating frame

Management's 2026 adjusted EBITDA outlook is USD 280 million to USD 300 million, according to Yahoo Finance. The same report linked the quarter's performance to improved cash collections, favorable payer mix and recent acquisitions, while higher operating costs limited the margin benefit.

The counter-factor is volume. Yahoo Finance said full-year patient volumes are expected to be flat to slightly lower, while the benefit from stronger revenue-cycle collections is expected to ease in the second half of 2026.

Analysts see limited upside

MarketBeat reported on September 25, 2026, that six research firms carried a consensus Hold rating, with five Holds and one Buy. Their average 12-month price target was USD 26.60, which is USD 0.94 above the September 24 price.

Stock remains below yearly high

MD had a market capitalization of USD 2,107,247,954 and volume of 681,833 shares on September 24, 2026. The stock's 52-week range was USD 15.70 to USD 27.94, while the latest daily change was down 0.77 percent from the prior close of USD 25.86.